The AABB website is currently experiencing technical issues related to login and SSO. Thank you for your patience as we work to get this resolved. If you need immediate assistance, please contact us.
Infectious diseases present a potential risk to the transfusion recipient and may impact the safety and adequacy of the blood supply. To protect both donor and patient health, all donors must meet eligibility requirements specified by the Food and Drug Administration and by AABB Standards and Accreditation Programs.
Donor eligibility is determined based on pre-donation donor screening with the Donor History Questionnaire, followed by additional testing. The post-donation testing of donor’s blood is performed before blood and blood components can be labeled for distribution. These critical, overlapping steps reduce the risk of transfusion-transmitted infection for the patient.
AABB works with FDA to ensure appropriate eligibility requirements are in place and to inform AABB members of current and emerging infectious disease risks. Learn more about these infectious diseases using the links below.
AABB is now the Association for the Advancement of Blood & Biotherapies. Learn more about our new name and brand – and watch as we evolve throughout 2022.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
AABB (Association for the Advancement of Blood & Biotherapies) is an international, not-for-profit organization representing individuals and institutions involved in the fields of transfusion medicine and biotherapies. The Association works collaboratively to advance the field through the development and delivery of standards, accreditation and education programs. AABB is dedicated to its mission of improving lives by making transfusion medicine and biotherapies safe, available and effective worldwide.
©2022 All Rights Reserved. AABB - Association for the Advancement of Blood & Biotherapies
Web Design and Development by Matrix Group International, Inc.